For decades, obesity has been framed as a lifestyle issue, a consequence of eating too much and moving too little. And yet, research in metabolic physiology, neuroendocrinology and genetics has fundamentally changed our understanding of the condition. Body weight is regulated by complex biological systems – governed by the brain through appetite, hormonal signalling and energy expenditure – in ways that differ from person to person. Genetic variation in hormonal pathways involving leptin and ghrelin directly influences how individuals regulate appetite and weight.
The World Health Organization (WHO) formally classified obesity as a chronic disease over twenty years ago. The UK has not followed suit, and the result is a healthcare system that has struggled to operationalise obesity care with the same consistency it applies to other long-term conditions, leaving patients navigating fragmented, episodic support rather than the structured, long-term management we would consider standard for conditions such as diabetes or cardiovascular disease. Some will argue that recognition risks over-medicalising a lifestyle issue, but obesity is influenced by behaviour, not reducible to it. Recognising it as a disease does not exclude lifestyle intervention, it strengthens it by placing behavioural support within a clinical framework that acknowledges the biological drivers patients are working against.
Nearly two-thirds of adults in England (64.5%) are overweight or living with obesity, one of the highest rates in Western Europe. Those are not abstract figures, they represent millions of people managing a chronic condition without the clinical framework that should exist to support them.
Read the article in full here.